Nursery fragmentation fuels consolidation

Look past this quarter's headline pharma deals and hospital group takeovers, and one of the more revealing stories in UK healthcare M&A is playing out somewhere quieter: the nursery sector. 

Eight transactions. 14% of all deal flow in Q2 2026. No billion-pound price tags, no listed targets, yet arguably one of the clearest illustrations we've seen this year of what happens when a fragmented, owner-managed market meets patient consolidation capital.

At Heligan, we spend as much time watching where deal volume concentrates as we do watching where deal value sits because volume tells you where an industry is actually being reshaped, deal by deal, nursery by nursery. This quarter, that story belongs to childcare. Here's what the data tells us, and why we think it matters for owners, operators and investors watching the wider care economy.

Inside look at the deal volume

The nursery market was one of the most active subsectors in UK healthcare M&A during Q2 2026. The transactions made up of 14% of deals across the quarter, representing a meaningful concentration of deal flow in a single, well-defined segment of the care economy.

The eight nursery transactions are set out below. In each case, enterprise value and associated valuation multiples were not publicly disclosed, which is consistent with the private, predominantly owner-managed nature of most nursery businesses trading in the UK.

The absence of private equity as a direct acquirer across the transactions is notable but should not be misread as a lack of sponsor interest. In this segment, private equity often sits behind the operating platform rather than appearing directly at the deal table. Kids Planet is backed by Fremann Capital, Storal is backed by Graphite Capital, and Happy Days is majority-owned by Zetland Capital Partners. As a result, a meaningful proportion of the quarter's activity remains sponsor-driven in substance, even where the direct buyer is an operating company.

The strategic rationale is clear. The UK nursery market remains fragmented, with many independent, owner-managed settings facing rising staffing costs, tighter regulatory demands and increasing administrative complexity around funded childcare hours. For larger operators, this creates a compelling consolidation opportunity: acquire smaller nurseries, professionalise operations, improve utilisation and benefit from procurement, systems and management efficiencies.

Broader market intelligence suggests nursery assets generally trade in the region of 5x to 10x EBITDA, with pricing driven by scale, occupancy, site quality, location, management depth and the balance between private-pay and government-funded income.

What’s coming next

We don't expect this to stop at just eight deals. What we're watching is the slow, methodical professionalisation of a sector built on thousands of small, dedicated operators, people who built something they care about and are now grappling with staffing costs, funded-hours administration and regulatory demands that were never designed with a five-room nursery in mind. For many of them, the consolidator arriving on their doorstep isn't a threat to what they built. It's a way of protecting it and giving it room to grow.

It's a pattern we keep coming back to across UK healthcare and care: fragmentation isn't a weakness. It's an opportunity waiting for the right operator, the right capital structure and the right advice to unlock it. Nurseries are this quarter's clearest example. We wouldn't be surprised to see a similar dynamic take hold elsewhere in the care economy before the year is out, and we'll be watching for it.

If you're building a nursery platform, sit behind one as a sponsor or are simply wondering whether how to protect the value you've spent years growing, we'd welcome the conversation. Spotting where a market is heading before it gets there is what we do, on nurseries and across the rest of the healthcare sector. We see things differently, and we're glad to share that view with you.